Bulletin
Investor Alert

Oct. 4, 2021, 4:34 p.m. EDT

Innovative Technology Coming for Marijuana Testing in the Workplace

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Cannabix Technologies Inc. (BLO)
  • X
    Cannabix Technologies Inc. (BLOZF)

or Cancel Already have a watchlist? Log In

Oct 04, 2021 (The Kerplunk) -- The world is a much different place for cannabis users compared to only a few years ago. Nearly 45% of U.S. adults live in a jurisdiction where recreational marijuana has been legalized1. As U.S. and Canadian societies change, the workplace will inevitably change with them. It is now a very real concern that employees may show up impaired, and testing methods need to keep pace with the speed of legalization. Urinalysis is the most common method of detecting THC use in the workplace - with the caveat that it can pick up usage from up to thirty days ago2, far beyond the window of impairment, which is a relatively short period of time after smoking.

The Rising Rate of Cannabis Usage in the Workplace

Studies suggest specific links between marijuana use and adverse consequences in the workplace, such as increased risk for injury or accidents3. 2020 saw an increase in the percentage of U.S. workers who tested positive for marijuana, tied to its legalized usage for medical and recreational use. Quest Diagnostics, a well-known drug testing laboratory, reported rates increasing by double digits. A recent Canadian study4 done with over 1600 workers showed that a quarter of respondents used cannabis before and/or at work. Respondents reporting workplace use were more likely to report more frequent cannabis use, use for medical or mixed purposes, and high THC cannabis use than workers reporting non-workplace use.

Innovative Technologies Coming to Meet New Testing Challenges

Cannabix Technologies /zigman2/quotes/206089806/delayed CA:BLO -1.89% /zigman2/quotes/203462343/delayed BLOZF +0.68% is developing an innovative product that will simplify the detection of THC-impairment in the workplace: a breathalyzer that will detect THC using breath samples. After marijuana use, the aerosol particles in exhaled breath that are formed from the respiratory tract lining fluid contain THC and metabolites for a relatively short period of time (1-3 hours), which aligns with the peak impairment window. By using a breathalyzer to detect them, employers would be able to quickly and accurately determine recent marijuana consumption versus just drug presence in urine.

Cannabix's new technology will allow for more relevant THC detection from breath, allowing employers to create an onsite regiment whereby they can perform pre-access testing for recent use of marijuana before and during work hours instead of testing for drug use when employees are not at work.

The Takeaway

As Cannabix scientists quickly develop this groundbreaking technology, they do so understanding that their products may have significant ramifications across many industries. For employers, this kind of solution would provide a fairer and more relevant way to administer THC-drug testing in their businesses.

The post Innovative Technology Coming for Marijuana Testing in the Workplace appeared first on The Kerplunk .

COMTEX_394563826/2664/2021-10-04T16:33:43

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/206089806/delayed
CA : Canadian Securities Exchange
$ 0.52
-0.01 -1.89%
Volume: 7,550
May 20, 2022 3:24p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$60.50 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/203462343/delayed
US : U.S.: OTC
$ 0.42
+0.0028 +0.68%
Volume: 63,951
May 20, 2022 3:42p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$47.20 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.